Bal Pharma Limited Annual Report 2026

To To Date: August 26, 2026 Listing Compliance Department BSE Limited National Stock Exchange of India Limited, 1st Floor, New Trading Ring, Exchange Plaza, 5th Floor, Plot No. C/2, G Block, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai-400051 Mumbai – 400001 Symbol: BALPHARMA Scrip Code: 524824 Sub: Annual Report of the Company for the Financial Year 2025-26 under Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'). Dear Sir/Madam, Pursuant to Regulation 34(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we are enclosing herewith copy of our Annual Report 2025-26 along with the Notice of the 39th AGM of the members of the Company which is being circulated to our members by email. Further, in accordance with Regulation 36(1)(b) of the SEBI Listing Regulations, a letter containing the web-link and path for accessing the Annual Report for FY2025-26 is being sent to all those Members who have not registered their email IDs with the Company/RTA/DPs. Said annual report available on the website of the Company at www.balpharma.com Weblink : https://www.balpharma.com/balpharmacom/pdf/investors/ar/ar2025-2026.pdf Please takes this intimation on your records Thanking You. For Bal Pharma Limited Shreepada ML Company Secretary and Compliance officer ICSI M No : A66681 Enclosure: Annual Report FY 2025-26 ANNUAL REPORT 2029-26 BUILDING A HEALTHIER TODAY FOR A BETTER TOMORROW COMMITTED TO QUALITY HEALTH CARE Fi WRRUEARANEOM BAL PHARMA LIMITED COMPANY PROFILE CIN : L85110KA1987PLC008368 Registered Office : 21-22, Bommasandra, Industrial Area, Bommasandra Industrial Estate, Bangalore, Bangalore South, Karnataka, India, 560099 Corporate Office : 5th Floor Lakshmi Narayan Complex, 10/1 Palace Road Bengaluru, Chickpet, Bangalore, Bangalore South, Karnataka, India, 560053 Equity Shares Listed at : BSE and NSE Email ID : investors@balpharma.com Website : www.balpharma.com BOARD OF DIRECTORS AND KMPs 1. Shailesh Siroya – Chairman and Managing Director 2. Virupakshaya Himesh – Whole Time Director 3. Ravindrakumar Kothari - Non Executive Director 4. Mr. Jatish Sheth - Independent Director 5. Ms. Nicola Neeladri - Independent Director 6. Mr. Bheekamchand Mukesh - Independent Director Mr. Bharath Bhushan D V – Chief Financial Officer Mr. Shreepada ML – Company Secretary and Compliance officer (w.e.f June 23 ,2026) Nomination & Stakeholders Relationship Audit Committee Remuneration Committee Committee Mr. Jatish Sheth - Chairman Mr. Jatish Sheth - Chairman Mr. Jatish Sheth - Chairman Ms. Nicola Neeladri - Member Ms. Nicola Neeladri - Member Ms. Nicola Neeladri - Member Bheekamchand Mukesh - Member Bheekamchand Mukesh - Member Bheekamchand Mukesh - Member Ravindrakumar Kothari -Member Ravindrakumar Kothari -Member Shailesh Siroya -Member STATUTORY AUDITORS SECRETARIAL AUDITORS INTERNAL AUDITORS COST AUDITORS Messrs SSJNB & Co, Chartered Mr. Parameshwar G Bhat Messrs Murugesh & Company GNV & Associates, Accountants , Bangalore Practicing Company Secretary Chartered Accountant , Cost Auditors Bangalore Bangalore Bangalore REGISTRAR & TRANSFER AGENTS BANKERS MUFG INTIME INDIA PRIVATE LIMITED HDFC Bank (Registrar & Transfer Agents) Canara Bank C 101, Embassy 247, L.B.S.Marg, Vikhroli (West) Federal Bank MUMBAI - 400 083 COMPANY PROFILE PLANT LOCATION Formulations API’s and Intermediates Unit 1 – Formulations Unit 2 - API’s # 21 & 22, Bommasandra # 61/B, Bommasandra Industrial Area Bangalore-560099. Karnataka. Industrial Area, Bangalore-560099. Karnataka. Unit 5 – Intermediates Thabadewadi Post, Kavatha Mahankal , Sangli-416405, Maharashtra. Unit 4 – Formulations Plot # 1,2,3&69, Sector 4, IIE-Pantnagar Unit 6 – API’s and Intermediates Rudrapur, Udham Singh Nagar – 263153, # C-155, Mewar Industrial Area Madri, Udaipur 313001, Rajasthan. Uttarakhand. SUBSIDIARY COMPANIES Lifezen Healthcare Private Limited Aurum Research & Analytical Solutions Private Limited CIN : U24230KA2014PTC077114 Registered Office : 5th Floor Lakshmi Narayan Complex, CIN : U72100KA2023PTC177577 Bengaluru, Chickpet, Bangalore, Bangalore South, 560053 Registered Office : #21 & 22, Bommasandra, Indl Estate, Hosur Rd, Bommasandra Industrial Estate, Bangalore, Bangalore South, 560099 Board of Directors: Shailesh Siroya - Director Board of Directors: Ravindrakumar Kothari - Director Shailesh Siroya - Director Ravindrakumar Kothari - Director Bal Research Foundation Balance Clinics LLP CIN : U73100KA2014NPL076995 LLPIN : AAC-3012 Registered Office : # 61-B, Bommasandra Industrial Area, Registered Office : 22/1, 5th cross BBMP Ward No. 78, Anekal Taluk, Vasanth Nagar, Bangalore, Chickpet, Bangalore 560053 Bangalore, 560099 Designated Partners : Board of Directors: Shailesh Siroya - Designated Partner Shailesh Siroya - Director Ravindrakumar Kothari - Designated Partner Ravindrakumar Kothari - Director ANNUAL REPORT INDEX Sl No Contents Page No Statutory Reports 01 AGM Notice 01 - 17 02 Board’s Report 18 - 50 03 Corporate Governance Report 51 - 71 04 Management Discussion and Business Analysis Report 72 - 74 Standalone Financial Statements 05 Audit Report 75 - 84 06 Balance sheet 85 - 86 07 Statement of Profit & Loss 87 - 88 08 Cash Flow Statement 89 - 90 09 Statement of change in equity 91 10 Notes to Financial Statements 92 - 143 Consolidation Financial Statements 11 Audit Reports 144 - 150 12 Balance sheet 151 - 152 13 Statement of Profit & Loss 153 - 154 14 Cash Flow Statement 155 - 156 15 Statement of change in equity 157 16 Notes to Financial Statements 158 - 205 AGM at a Glance 39th Annual General Meeting of Bal Pharma Limited - Information at a Glance Sl No P articulars D e t a i ls 01 Day, Date and Time of the AGM Thursday, 24th September, 2026, 11:30 A.M 02 Mode Video Conference (‘VC’) and Other Audio-Visual Means ( ‘OAVM’) 03 Link for e- voting & participation Members may access the same at in the AGM through VC/OAVM www.evoting.nsdl.com under Shareholders/Members login by using the remote e-voting credentials 04 Helpline number for VC participation NSDL: 022 - 4886 7000 and e-voting CDSL: 1800-21-09911 05 Email IDs for any assistance or support NSDL: evoting@nsdl.co.in for VC participation and e-voting CDSL: evoting@cdslindia.com 06 Record Date / Cut-off date for e-voting 17th September, 2026 07 Book closure Friday, 18th September, 2026 to Thursday, 24th September, 2026 (both days inclusive) 08 E-voting start time and date 21st September, 2026 (9:00 am IST) 09 E-voting end time and date 23rd September, 2026 (5:00 pm IST) 10 E-Voting website NSDL : www.evoting.nsdl.com CDSL : www.evoting.cdslindia.com/Evoting/EvotingLogin 11 Record date for Final dividend for 17th September, 2026 Financial Year 2025-26 12 Company Contact details for Speaker investor@balpharma.com registration and any other matters 13 Company Website for download AGM www.balpharma.com Notice & Annual report AGM NOTICE NOTICE is hereby given that the 39th (Thirty Ninth) Annual “RESOLVED THAT pursuant to the provisions of Section 152 and General Meeting (AGM) of the Members of Bal Pharma Limited will other applicable provisions, if any, of the Companies Act, 2013, the be held on Thursday, 24th September, 2026 at 11:30 A.M through Companies (Appointment and Qualification of Directors) Rules, Video Conference (“VC”) / Other Audio Visual Means (“OAVM”), to 2014, Regulation 17 of the SEBI (Listing Obligations and Disclosure transact the following business: Requirements) Regulations, 2015, and the Articles of Association of the Company, Mr. Ravindra Kumar Kothari (DIN : 03418320), who ORDINARY BUSINESS: retires by rotation at this meeting, being eligible and having offered himself for re-appointment, be and is hereby re-appointed as a 1. To receive, consider and adopt the Audited Standalone and Director of the Company. Consolidated Financial Statements of the Company for the fin [Showing first 8,000 characters — download PDF for full document]